// App-Quantinova.ai

OP0255 (2018) : Identification of clinical and serological predictive factors of response to rituximabtreatment in systemic lupus erythematosus (SLE patients

Researchers

Presenter

  • H. Sánchez Pérez

Principal Investigators

  • D. Isenberg

Medical Centers

  • Hospital Universitario de Canarias, La Laguna, Spain

  • Centre for Rheumatology Division of Medicine, University College London, London, UK

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A


Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A